RUMORED BUZZ ON IBRUTINIB

In August 2022 enrollment began on a research assessing the result of semaglutide on tau accumulation from the brains of people who find themselves amyloid-positive, with or without having diabetes, and with no or mild cognitive impairment (Koychev et al., 2024). The research at the College of Oxford in the U.K. will deal with 88 individuals with a